3Dinan MA,Curtis LH,Hammill BG,et al.Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer,1999-2006[J].JAMA,2010,303(16):1625-1631.
4van Tinteren H,Hoekstra OS,Smit EF,et al.Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer:the PLUS multicentre randomised trial[J].Lancet,2002,359(9315):1388-1393.
5Fischer B,Lassen U,Mortensen J,et al.Preoperative staging of lung cancer with combined PET-CT[J].N Engl J Med,2009,361(1):32-39.
6Bussink J,Kaanders JH,van der Graaf WT,et al.PET-CT for radiotherapy treatment planning and response monitoring in solid tumors[J].Nat Rev Clin Oncol,2011,8(4):232-242.
7Hall E,Giaccia A.Radiobiology for the radiologist.6thed.[M].Lippincott Williams&Wilkins,2006:192-199.
8Dinan MA, Cus LH, Hammill BG, et al. Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneneiaries With Cancer, 1999 - 2006 [ J ]. JAMA ,2010,303 (16) : 1625 - 1631.
9Fischer B,Lassen U, Mortensen J,et al. Preoperative staging d lung cancer with combined PET - CTE J]. N Engl J Med ,2009 ,361 ( 1 ) : 32 - 39.
10Bussink J,Kaandem JH, van der Grad WT,et al. PET - CT far ra- diotherapy treatment plann/ng and response monitoring in solid tumors[J. Nat Rev Clin Oneol,2011,8(4) :232 -242.
